Author:
Schellhammer Paul F.,Chodak Gerald,Whitmore James B.,Sims Robert,Frohlich Mark W.,Kantoff Philip W.
Reference24 articles.
1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012
2. Sipuleucel-T in metastatic castration-resistant prostate cancer;Plosker;Drugs,2011
3. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;Kantoff;N Engl J Med,2010
4. Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer;Small;J Clin Oncol,2006
5. Higano CS, Saad F, Somer B, et al. A phase III trial of GVAX immunotherapy for prostate cancer versus docetaxel plus prednisone in asymptomatic, castration-resistant prostate cancer (CRPC). Presented at the 2009 Genitourinary Cancers Symposium. February 26-28, 2009: Orlando, FL. Available at: http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=64&abstractID=20295. Accessed May 25, 2011.
Cited by
197 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献